Brief: Chimeric Therapeutics Seeks Trading Halt
17/08/2026 24:55
BRIEF-Chimeric Therapeutics Seeks Trading Halt Aug 17 (Reuters) - Chimeric Therapeutics Ltd CHM.AX:
SECURITIES PLACED IN TRADING HALT PENDING ANNOUNCEMENT ON RESULTS OF CDH17 CLINICAL TRIAL
Further company coverage: CHM.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial